Transarterial chemoembolization plus a PD‐1 inhibitor with or without lenvatinib for intermediate‐stage hepatocellular carcinoma-Reference-Cited by-同舟云学术

Transarterial chemoembolization plus a PD‐1 inhibitor with or without lenvatinib for intermediate‐stage hepatocellular carcinoma

Published:2022-05-22 Issue:8 Volume:52 Page:721-729
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Xiang Yan‐Jun¹²^ORCID,Wang Kang¹,Yu Hong‐Ming¹,Li Xiao‐Wei³,Cheng Yu‐Qiang¹,Wang Wei‐Jun¹,Feng Jin‐Kai¹,Bo Meng‐Han⁴,Qin Ying‐Yi⁵,Zheng Yi‐Tao²,Shan Yun‐Feng²,Zhou Li‐Ping¹,Zhai Jian³,Cheng Shu‐Qun¹²

Affiliation:

1. Department of Hepatic Surgery VI Eastern Hepatobiliary Surgery Hospital Naval Medical University Shanghai China

2. Department of Hepatobiliary Surgery The First Affiliated Hospital Wenzhou Medical University Wenzhou China

3. Department II of Interventional Radiology Eastern Hepatobiliary Surgery Hospital Naval Medical University Shanghai China

4. Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine Shanghai China

5. Department of Health Statistics Naval Medical University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13773

Reference40 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma

3. Recurrence of Hepatocellular Cancer After Resection

4. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of Radiofrequency ablation combined with Lenvatinib plus Sintilimab in Unresectable Hepatocellular Carcinoma: a real-world study;BMC Cancer;2024-08-22

2. Comparison of the efficacy and safety of immunotherapy combined with lenvatinib at different time points in unresectable hepatocellular carcinoma: a single-center retrospective study;2024-06-12

3. Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate‐stage Hepatocellular Carcinoma: A Multicenter Retrospective Study;Journal of Hepatocellular Carcinoma;2024-06

4. Sorafenib plus transcatheter arterial chemoembolization with or without camrelizumab for the treatment of intermediate and advanced hepatocellular carcinoma;British Journal of Radiology;2024-05-07

5. Comparison of tumor response and outcomes of patients with hepatocellular carcinoma after multimodal treatment including immune checkpoint inhibitors – a systematic review and meta-analysis;HPB;2024-05